These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations]. MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604 [No Abstract] [Full Text] [Related]
6. [Milestones in inhalation therapy of airway diseases]. Wettengel R Med Klin (Munich); 2002 Dec; 97 Suppl 2():7-11. PubMed ID: 12593175 [TBL] [Abstract][Full Text] [Related]
7. Editing the COPD guidelines. Lertzman M Can Respir J; 2000; 7(1):29-30. PubMed ID: 10700668 [No Abstract] [Full Text] [Related]
8. The use of two inhaled beta agonists for the treatment of COPD: a summary of European data. Holten K; Lulling J; Schaaning J; Vander Straeten M; Verstraeten JM J Asthma; 1993; 30(2):123-6. PubMed ID: 8096208 [No Abstract] [Full Text] [Related]
9. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD. Teramoto S; Fukuchi Y; Ouchi Y Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538 [No Abstract] [Full Text] [Related]
10. Teaching correct use of inhaled medications. Rokosky JM Home Healthc Nurse; 2005 Dec; 23(12):766-74; quiz 775-6. PubMed ID: 16331059 [No Abstract] [Full Text] [Related]
11. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Yates DH; Kharitonov SA; Barnes PJ Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents]. Nishimura K; Ikeda A; Koyama H; Tsukino M; Hajiro T; Izumi T Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():75-8. PubMed ID: 9216189 [TBL] [Abstract][Full Text] [Related]
14. Inhaled beta-2 agonists and steroids. Present state and future perspectives. Clauzel AM Clin Rev Allergy; 1994; 12(1):43-64. PubMed ID: 7915191 [No Abstract] [Full Text] [Related]
15. Newer therapeutic agents for asthma. Deykin A; Israel E Adv Intern Med; 1999; 44():209-37. PubMed ID: 9929710 [TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective. Yernault JC Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959 [No Abstract] [Full Text] [Related]
17. Use of 'Fixed' combination preparations of inhaled short acting b-2 agonists and inhaled corticosteroids. Gupta A Indian Pediatr; 2000 Jul; 37(7):752-4. PubMed ID: 10906807 [No Abstract] [Full Text] [Related]
18. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Mahler DA; Wire P; Horstman D; Chang CN; Yates J; Fischer T; Shah T Am J Respir Crit Care Med; 2002 Oct; 166(8):1084-91. PubMed ID: 12379552 [TBL] [Abstract][Full Text] [Related]
20. [Classics with innovative potential noted. The MMW drug prize for inhalative airway therapeutics]. Füessl HS MMW Fortschr Med; 2002 Feb; 144(8):13. PubMed ID: 11910815 [No Abstract] [Full Text] [Related] [Next] [New Search]